FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets RAS pathway related proteins
| | | | | Mixed |
FKBP5 | FK506 binding protein 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
FOSL1 | FOS-like antigen 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
FSCN1 | Fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
G6PD | Glucose-6-phosphate dehydrogenase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
GCLM | Glutamate-cysteine ligase, modifier subunit | Cancer-related genes
| | | | | Expressed in all |
GNAS | GNAS complex locus | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
GPI | Glucose-6-phosphate isomerase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
GSN | Gelsolin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GSR | Glutathione reductase | Cancer-related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
GSTM3 | Glutathione S-transferase mu 3 (brain) | Cancer-related genes Enzymes
| | | | | Expressed in all |
GSTP1 | Glutathione S-transferase pi 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
HDAC2 | Histone deacetylase 2 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
HSF1 | Heat shock transcription factor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
HSP90B1 | Heat shock protein 90kDa beta (Grp94), member 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
HSPA4 | Heat shock 70kDa protein 4 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
HSPB1 | Heat shock 27kDa protein 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
HSPD1 | Heat shock 60kDa protein 1 (chaperonin) | Cancer-related genes Disease related genes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
HSPH1 | Heat shock 105kDa/110kDa protein 1 | Cancer-related genes
| | | | | Expressed in all |
IL18 | Interleukin 18 (interferon-gamma-inducing factor) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins
| | | | | Expressed in all |
IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
ITGA3 | Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ITGB1 | Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
JUN | Jun proto-oncogene | Cancer-related genes FDA approved drug targets Transcription factors
| | | | | Expressed in all |
KRT13 | Keratin 13 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
KRT18 | Keratin 18 | Cancer-related genes Disease related genes
| | | | | Mixed |
KRT8 | Keratin 8 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Mixed |
LGALS3 | Lectin, galactoside-binding, soluble, 3 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
LIMK1 | LIM domain kinase 1 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
LMNA | Lamin A/C | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
LTA4H | Leukotriene A4 hydrolase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MAGI1 | Membrane associated guanylate kinase, WW and PDZ domain containing 1 | Cancer-related genes Plasma proteins
| | | | | Mixed |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MCM2 | Minichromosome maintenance complex component 2 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MCM3 | Minichromosome maintenance complex component 3 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MCM5 | Minichromosome maintenance complex component 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MCM7 | Minichromosome maintenance complex component 7 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MGMT | O-6-methylguanine-DNA methyltransferase | Cancer-related genes Enzymes
| | | | | Expressed in all |
MIF | Macrophage migration inhibitory factor (glycosylation-inhibiting factor) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MTA1 | Metastasis associated 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MVP | Major vault protein | Cancer-related genes Cytoskeleton related proteins
| | | | | Expressed in all |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NEDD8 | Neural precursor cell expressed, developmentally down-regulated 8 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Cancer-related genes FDA approved drug targets Plasma proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
NFKB2 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
NFKBIE | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | Cancer-related genes Transcription factors
| | | | | Mixed |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |